Last Updated: May 10, 2026

Claims for Patent: 9,254,321

✉ Email this page to a colleague

Summary for Patent: 9,254,321

Title:	Compositions and methods for stabilizing protein-containing formulations
Abstract:	The present invention relates to use of certain alkylglycoside compositions for the prevention of aggregation and oxidation of antibodies and other proteins in therapeutically useful formulations thereof.
Inventor(s):	Osigwe Esue, Vikas K. Sharma
Assignee:	Genentech Inc
Application Number:	US13/722,559

Details for Patent 9,254,321

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Genentech, Inc.	RAPTIVA	efalizumab	Injection	125075	October 27, 2003	⤷ Start Trial	2032-12-20
Kiniksa Pharmaceuticals (uk), Ltd.	ARCALYST	rilonacept	For Injection	125249	February 27, 2008	⤷ Start Trial	2032-12-20
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 9,254,321

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
South Africa	201209539	⤷ Start Trial
World Intellectual Property Organization (WIPO)	2011163458	⤷ Start Trial
United States of America	2021353756	⤷ Start Trial
United States of America	2019216929	⤷ Start Trial
United States of America	2016199494	⤷ Start Trial
United States of America	2013224213	⤷ Start Trial
United States of America	11938189	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.